Akèy › Skleroz an milti pwogresif kwonik › Arizona › Scottsdale
Etid klinik pou Skleroz an milti pwogresif kwonik nan Scottsdale, AZ
3 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan ak bò kote Scottsdale (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- Perseverance Research Center, LLC (PRC), Scottsdale
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Ap rekriteFaz 4
- Clinical Endpoints, LLC, Scottsdale
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- Perseverance Research Center, Scottsdale
Etid Skleroz an milti pwogresif kwonik nan lòt vil
- Chicago, IL4 etid
- St. Louis, MO4 etid
- Orlando, FL4 etid
- Memphis, TN4 etid
- Kansas City, KS3 etid
- Columbus, OH3 etid
- Greenville, SC3 etid
- Tampa, FL3 etid
- Burbank, CA3 etid
Lòt etid nan Scottsdale
- Kansè (tout kalite)18 etid
- Kansè nan tete18 etid
- Kansè Metastatik17 etid
- Kansè pwostat17 etid
- Kansè Poumon ki pa ti selil15 etid
- Kansè kolorektal15 etid
- Kansè pankreyas13 etid
- Melanom10 etid
- Kolit Ulseratif8 etid
- Kansè poumon8 etid
- Maladi Alzheimer7 etid
- Kansè fwa (Kasinòm epatoselilè)7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.